Psychology & Psychiatry

Why we need a scientific approach to mental health at work

With businesses looking to support the mental health of their staff more than ever, Wellcome is urging them to take a science-based approach. Miranda Wolpert shares what we've learned so far about what works for supporting ...

Diseases, Conditions, Syndromes

Vaccine concerns divide nations at Davos

Divisions were on display Tuesday at the Davos virtual summit as nations called for fair distribution of COVID-19 vaccines amid fears of hoarding by rich nations.

Vaccination

EU demands that vaccine makers honor their commitments

The European Union on Tuesday warned pharmaceutical giants that develop coronavirus vaccines to honor their contractual obligations after slow deliveries of shots from two companies hampered the bloc's vaunted vaccine rollout ...

Diseases, Conditions, Syndromes

France vows faster vaccine rollout after criticism

France promised on Tuesday to speed up COVID vaccinations, but failed to silence harsh critics who said the government's rollout was scandalously slow and inept.

Diseases, Conditions, Syndromes

Millions of Californians locked down, UK to start vaccinating

Southern California went into lockdown Monday putting 20 million people under stay-at-home orders as the United States battles record COVID deaths and Britain readied to vaccinate the elderly and frontline staff.

Vaccination

Drug companies work jointly to boost vaccine confidence

Two firms developing COVID-19 vaccines say pharmaceutical companies are trying to give the public as much information as possible about their testing regimes as drugmakers and public health officials seek to boost confidence ...

Diseases, Conditions, Syndromes

Africa, Latin America fragile targets for coronavirus spread

The West African nation of Mali has roughly one ventilator per 1 million of its people—20 in all to help the critically ill. In Peru, with more than 32 million people, about 350 beds in intensive care units exist.

Diseases, Conditions, Syndromes

Britain's GSK joins race to develop China virus vaccine

UK pharmaceuticals giant GlaxoSmithKline (GSK) said Monday it was joining a global race to develop a vaccine for a new strain of a coronavirus that has killed more than 360 people.

page 2 from 4